Companion Diagnostics Market 2018 by Product Type, Top Manufacturers, Production, Revenue, Market Share, and Forecast

Companion Diagnostics

Companion Diagnostics Market covers worldwide information and accurate data about Companion Diagnostics Industry, with a complete study of market-based on market drivers, market challenges, future trends. Companion Diagnostics market also provides analysis by type, application, regions, manufacturers, technology, new entrants, raw materials analysis, manufacturing process.

Global Companion Diagnostics market is projected to reach a CAGR of 22.7% between 2018 and 2023.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in at

Top Manufacturers in Companion Diagnostics Market: – Abbott Laboratories, Dako (Agilent Technologies), Roche Holdings, Qiagen NV, Seimens Helthineers, Takeda Pharmaceuticals, Myriad Genetics, Thermo Fisher Scientific, Tacogen, Illumina Inc.and many more.

Companion Diagnostics Market Dynamics

  • Drivers
    – Companies Promoting Personalized Medicine and Targeted Therapy as a New Treatment Option
    – Increasing Cases of Adverse Drug Reactions
    – Co-Development of Drug and Diagnostic Technology
  • Restraints
    – High Cost Of Drug Development and Associated Clinical Trials
    – Reimbursement Issues among Many Countries

    Key Developments in the Companion Diagnostics Market:

  • January 2018: Myriad Genetics received FDA approval for BRACAnalysis CDx as Companion Diagnostic for Lynparza (olaparib).
  • January 2018: A new companion diagnostics agreement between Biocartis Group and Amgen was signed for the development of Idylla™ CDx biomarker tests, used in the treatment of certain solid tumors.
  • December 2017: HTG Molecular Diagnostics signed master collaboration with Merck KGaA, complementing the companion diagnostics agreement for biomarker research program.

    Ask for Sample PDF of Report at

    Geographical Regions: – US, Canada, Mexico, UK, France, Germany, Italy, Spain, India, China, Japan, Australia, South Korea, GCC, South Africa, Brazil,Argentina

    Reasons to Purchase Companion Diagnostics Market Report Covered:

    • The report examines how Companion Diagnostics market will develop in the future.
    • Studying various views of the Companion Diagnostics market with the help of Porter’s five forces analysis.
    • Analyzing the product type that is probably to control the market and regions that are likely to witness the fastest development during the forecast period
    • Identify the new developments, Companion Diagnostics market shares and strategies employed by the key market players.
    • Competitive landscape including the market share of major players along with the key strategies accepted for growth in the past five years
    • Complete company profiles covering the product offerings, key financial information, current developments, SWOT analysis and strategies employed by the major Companion Diagnostics market players

    Price of Report: $ 4250 (Single User Licence)

    Purchase Market Report at

    Companion Diagnostics Market drives a strong trend of R&D investments in this industry. Other growth drivers include the need to curtail costs, growth and increased use of shifting commodity prices, the strength of private label brands and increased competition from players in Companion Diagnostics market.